Early B cell changes predict autoimmunity following combination immune checkpoint blockade
Das, Rituparna, Bar, Noffar, Ferreira, Michelle, Newman, Aaron M, Zhang, Lin, Bailur, Jithendra Kini, Bacchiocchi, Antonella, Kluger, Harriet, Wei, Wei, Halaban, Ruth, Sznol, Mario, Dhodapkar, Madhav V, Dhodapkar, Kavita M
Published in The Journal of clinical investigation (01.02.2018)
Published in The Journal of clinical investigation (01.02.2018)
Get full text
Journal Article
T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma
Lozano, Alexander X, Chaudhuri, Aadel A, Nene, Aishwarya, Bacchiocchi, Antonietta, Earland, Noah, Vesely, Matthew D, Usmani, Abul, Turner, Brandon E, Steen, Chloé B, Luca, Bogdan A, Badri, Ti, Gulati, Gunsagar S, Vahid, Milad R, Khameneh, Farnaz, Harris, Peter K, Chen, David Y, Dhodapkar, Kavita, Sznol, Mario, Halaban, Ruth, Newman, Aaron M
Published in Nature medicine (01.02.2022)
Published in Nature medicine (01.02.2022)
Get full text
Journal Article
Nivolumab plus Ipilimumab in Advanced Melanoma
Wolchok, Jedd D, Kluger, Harriet, Callahan, Margaret K, Postow, Michael A, Rizvi, Naiyer A, Lesokhin, Alexander M, Segal, Neil H, Ariyan, Charlotte E, Gordon, Ruth-Ann, Reed, Kathleen, Burke, Matthew M, Caldwell, Anne, Kronenberg, Stephanie A, Agunwamba, Blessing U, Zhang, Xiaoling, Lowy, Israel, Inzunza, Hector David, Feely, William, Horak, Christine E, Hong, Quan, Korman, Alan J, Wigginton, Jon M, Gupta, Ashok, Sznol, Mario
Published in The New England journal of medicine (11.07.2013)
Published in The New England journal of medicine (11.07.2013)
Get full text
Journal Article
Atezolizumab, an Anti-Programmed Death-Ligand 1 Antibody, in Metastatic Renal Cell Carcinoma: Long-Term Safety, Clinical Activity, and Immune Correlates From a Phase Ia Study
McDermott, David F, Sosman, Jeffrey A, Sznol, Mario, Massard, Christophe, Gordon, Michael S, Hamid, Omid, Powderly, John D, Infante, Jeffrey R, Fassò, Marcella, Wang, Yan V, Zou, Wei, Hegde, Priti S, Fine, Gregg D, Powles, Thomas
Published in Journal of clinical oncology (10.03.2016)
Published in Journal of clinical oncology (10.03.2016)
Get full text
Journal Article
Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial
Goldberg, Sarah B, Dr, Gettinger, Scott N, MD, Mahajan, Amit, MD, Chiang, Anne C, MD, Herbst, Roy S, Prof, Sznol, Mario, Prof, Tsiouris, Apostolos John, MD, Cohen, Justine, DO, Vortmeyer, Alexander, MD, Jilaveanu, Lucia, MD, Yu, James, MD, Hegde, Upendra, MD, Speaker, Stephanie, BA, Madura, Matthew, BS, Ralabate, Amanda, BSN, Rivera, Angel, MS, Rowen, Elin, MSN, Gerrish, Heather, BSN, Yao, Xiaopan, PhD, Chiang, Veronica, MD, Kluger, Harriet M, Prof
Published in The lancet oncology (01.07.2016)
Published in The lancet oncology (01.07.2016)
Get full text
Journal Article
Phase Ib Study of Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Combination with Pembrolizumab (MK-3475) in Patients with Advanced Solid Tumors
Tolcher, Anthony W, Sznol, Mario, Hu-Lieskovan, Siwen, Papadopoulos, Kyriakos P, Patnaik, Amita, Rasco, Drew W, Di Gravio, Donna, Huang, Bo, Gambhire, Dhiraj, Chen, Ying, Thall, Aron D, Pathan, Nuzhat, Schmidt, Emmett V, Chow, Laura Q M
Published in Clinical cancer research (15.09.2017)
Published in Clinical cancer research (15.09.2017)
Get full text
Journal Article
Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibody
Segal, Neil H, Logan, Theodore F, Hodi, F Stephen, McDermott, David, Melero, Ignacio, Hamid, Omid, Schmidt, Henrik, Robert, Caroline, Chiarion-Sileni, Vanna, Ascierto, Paolo A, Maio, Michele, Urba, Walter J, Gangadhar, Tara C, Suryawanshi, Satyendra, Neely, Jaclyn, Jure-Kunkel, Maria, Krishnan, Suba, Kohrt, Holbrook, Sznol, Mario, Levy, Ronald
Published in Clinical cancer research (15.04.2017)
Published in Clinical cancer research (15.04.2017)
Get full text
Journal Article
Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma
Wallin, Jeffrey J, Bendell, Johanna C, Funke, Roel, Sznol, Mario, Korski, Konstanty, Jones, Suzanne, Hernandez, Genevive, Mier, James, He, Xian, Hodi, F Stephen, Denker, Mitchell, Leveque, Vincent, Cañamero, Marta, Babitski, Galina, Koeppen, Hartmut, Ziai, James, Sharma, Neeraj, Gaire, Fabien, Chen, Daniel S, Waterkamp, Daniel, Hegde, Priti S, McDermott, David F
Published in Nature communications (30.08.2016)
Published in Nature communications (30.08.2016)
Get full text
Journal Article
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
Weber, Jeffrey S, Dr, D'Angelo, Sandra P, MD, Minor, David, MD, Hodi, F Stephen, MD, Gutzmer, Ralf, MD, Neyns, Bart, MD, Hoeller, Christoph, MD, Khushalani, Nikhil I, MD, Miller, Wilson H, MD, Lao, Christopher D, MD, Linette, Gerald P, MD, Thomas, Luc, MD, Lorigan, Paul, FRCP, Grossmann, Kenneth F, MD, Hassel, Jessica C, MD, Maio, Michele, MD, Sznol, Mario, MD, Ascierto, Paolo A, MD, Mohr, Peter, MD, Chmielowski, Bartosz, MD, Bryce, Alan, MD, Svane, Inge M, MD, Grob, Jean-Jacques, MD, Krackhardt, Angela M, MD, Horak, Christine, PhD, Lambert, Alexandre, PhD, Yang, Arvin S, MD, Larkin, James, FRCP
Published in The lancet oncology (01.04.2015)
Published in The lancet oncology (01.04.2015)
Get full text
Journal Article
Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas
Krauthammer, Michael, Kong, Yong, Bacchiocchi, Antonella, Evans, Perry, Pornputtapong, Natapol, Wu, Cen, McCusker, James P, Ma, Shuangge, Cheng, Elaine, Straub, Robert, Serin, Merdan, Bosenberg, Marcus, Ariyan, Stephan, Narayan, Deepak, Sznol, Mario, Kluger, Harriet M, Mane, Shrikant, Schlessinger, Joseph, Lifton, Richard P, Halaban, Ruth
Published in Nature genetics (01.09.2015)
Published in Nature genetics (01.09.2015)
Get full text
Journal Article
PD-L1 Studies Across Tumor Types, Its Differential Expression and Predictive Value in Patients Treated with Immune Checkpoint Inhibitors
Kluger, Harriet M, Zito, Christopher R, Turcu, Gabriela, Baine, Marina K, Zhang, Hongyi, Adeniran, Adebowale, Sznol, Mario, Rimm, David L, Kluger, Yuval, Chen, Lieping, Cohen, Justine V, Jilaveanu, Lucia B
Published in Clinical cancer research (01.08.2017)
Published in Clinical cancer research (01.08.2017)
Get full text
Journal Article
Integrative molecular and clinical profiling of acral melanoma links focal amplification of 22q11.21 to metastasis
Farshidfar, Farshad, Rhrissorrakrai, Kahn, Levovitz, Chaya, Peng, Cong, Knight, James, Bacchiocchi, Antonella, Su, Juan, Yin, Mingzhu, Sznol, Mario, Ariyan, Stephan, Clune, James, Olino, Kelly, Parida, Laxmi, Nikolaus, Joerg, Zhang, Meiling, Zhao, Shuang, Wang, Yan, Huang, Gang, Wan, Miaojian, Li, Xianan, Cao, Jian, Yan, Qin, Chen, Xiang, Newman, Aaron M, Halaban, Ruth
Published in Nature communications (23.02.2022)
Published in Nature communications (23.02.2022)
Get full text
Journal Article
Nivolumab plus Ipilimumab in Advanced Melanoma
WOLCHOK, Jedd D, KLUGER, Harriet, BURKE, Matthew M, CALDWELL, Anne, KRONENBERG, Stephanie A, AGUNWAMBA, Blessing U, XIAOLING ZHANG, LOWY, Israel, INZUNZA, Hector David, FEELY, William, HORAK, Christine E, QUAN HONG, CALLAHAN, Margaret K, KORMAN, Alan J, WIGGINTON, Jon M, GUPTA, Ashok, SZNOL, Mario, POSTOW, Michael A, RIZVI, Naiyer A, LESOKHIN, Alexander M, SEGAL, Neil H, ARIYAN, Charlotte E, GORDON, Ruth-Ann, REED, Kathleen
Published in The New England journal of medicine (11.07.2013)
Published in The New England journal of medicine (11.07.2013)
Get full text
Journal Article
Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma
Choueiri, Toni K, Fishman, Mayer N, Escudier, Bernard, McDermott, David F, Drake, Charles G, Kluger, Harriet, Stadler, Walter M, Perez-Gracia, Jose Luis, McNeel, Douglas G, Curti, Brendan, Harrison, Michael R, Plimack, Elizabeth R, Appleman, Leonard, Fong, Lawrence, Albiges, Laurence, Cohen, Lewis, Young, Tina C, Chasalow, Scott D, Ross-Macdonald, Petra, Srivastava, Shivani, Jure-Kunkel, Maria, Kurland, John F, Simon, Jason S, Sznol, Mario
Published in Clinical cancer research (15.11.2016)
Published in Clinical cancer research (15.11.2016)
Get full text
Journal Article
Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer
Fong, Lawrence, Hotson, Andrew, Powderly, John D, Sznol, Mario, Heist, Rebecca S, Choueiri, Toni K, George, Saby, Hughes, Brett G M, Hellmann, Matthew D, Shepard, Dale R, Rini, Brian I, Kummar, Shivaani, Weise, Amy M, Riese, Matthew J, Markman, Ben, Emens, Leisha A, Mahadevan, Daruka, Luke, Jason J, Laport, Ginna, Brody, Joshua D, Hernandez-Aya, Leonel, Bonomi, Philip, Goldman, Jonathan W, Berim, Lyudmyla, Renouf, Daniel J, Goodwin, Rachel A, Munneke, Brian, Ho, Po Y, Hsieh, Jessica, McCaffery, Ian, Kwei, Long, Willingham, Stephen B, Miller, Richard A
Published in Cancer discovery (01.01.2020)
Published in Cancer discovery (01.01.2020)
Get full text
Journal Article
Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial
Margolin, Kim, Prof, Ernstoff, Marc S, MD, Hamid, Omid, MD, Lawrence, Donald, MD, McDermott, David, MD, Puzanov, Igor, MD, Wolchok, Jedd D, MD, Clark, Joseph I, Prof, Sznol, Mario, MD, Logan, Theodore F, MD, Richards, Jon, MD, Michener, Tracy, PharmD, Balogh, Agnes, MS, Heller, Kevin N, MD, Hodi, F Stephen, MD
Published in The lancet oncology (01.05.2012)
Published in The lancet oncology (01.05.2012)
Get full text
Journal Article